Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Lung Neoplasms 22Leukemia, Myeloid, Acute 21Breast Neoplasms 19Neoplasm Metastasis 16Pancreatic Neoplasms 15Multiple Myeloma 14Prostatic Neoplasms 12Melanoma 12Lymphoma 11Colorectal Neoplasms 11Carcinoma, Renal Cell 11Carcinoma, Non-Small-Cell Lung 11Burkitt Lymphoma 10Triple Negative Breast Neoplasms 9Urinary Bladder Neoplasms 8Squamous Cell Carcinoma of Head and Neck 8Ovarian Neoplasms 8Myelodysplastic Syndromes 8Mouth Neoplasms 8Glioma 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Oropharyngeal Neoplasms 7Leukemia, Lymphocytic, Chronic, B-Cell 7Laryngeal Neoplasms 7Fallopian Tube Neoplasms 7Carcinoma, Hepatocellular 7Carcinoma 7Sarcoma 6Nasopharyngeal Carcinoma 6Endometrial Neoplasms 6

Interventions

Bevacizumab 3durvalumab 2atezolizumab 2Hepatectomy 2tremelimumab 1trastuzumab deruxtecan 1pembrolizumab 1Whole Genome Sequencing 1Standard of Care 1Specimen Handling 1Radionuclide Imaging 1Platinum 1Ipilimumab 1Immunotherapy 1Immunoglobulin G 1IMC-001 1Granulocyte-Macrophage Colony-Stimulating Factor 1Gemcitabine 1Disulfides 1Diathermy 1Cisplatin 1Cell- and Tissue-Based Therapy 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Liver Neoplasms × Specimen Handling × 30 days × Clear all
NCT05211323 2026-06-03

A Study to Determine Whether Chemotherapy and Atezolizumab is Better Than Chemotherapy, Bevacizumab and Atezolizumab in Patients With Advanced Liver Cancer

National Cancer Institute (NCI)

Phase 2 Active not recruiting
88 enrolled
Gastrointestinal

Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡